By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Zambon Group spa 

Via Lillo del Duca
20091 Bresso
Milan    10 - 20091  Italy
Phone: 39-02-665241 Fax: 39-02-66501492 / Tx. 330042


Company News
Zambon Launches Xadago (Safinamide) In Switzerland For Patients With Parkinson’s Disease 1/12/2016 11:57:08 AM
Newron Pharmaceuticals (NWRN) And Zambon Release: Swissmedic Approves Xadago (Safinamide) For Use In Parkinson’s Disease 11/13/2015 10:14:39 AM
Zambon Launches Xadago (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany 5/15/2015 9:05:33 AM
Zambon Release: Parkinson’s Disease (PD): EU Commission Approves Xadago (Safinamide) For Mid-Late Stage PD Patients 2/26/2015 11:02:41 AM
Newron Pharmaceuticals (NWRN) PD Drug Succeeds in Phase III, $26 Million Zambon Pact Sealed 5/16/2012 7:49:13 AM
Recordati S.p.A Signs An Agreement With Zambon For The Co-Marketing Of Silodosin In France 5/7/2010 11:26:38 AM
Zambon and Indena S.p.A. in Licensing Deal 10/26/2009 12:00:12 PM
Apotex Inc. Acquires Topgen E.S.V. in Belgium from Zambon 11/15/2007 8:29:29 AM
Pierre Fabre Medicament And Zambon Sign Commercial Agreement In Germany 2/21/2007 5:14:34 PM
Newron Pharmaceuticals And Zambon Sign Collaboration To Develop Novel Treatments For Pain Conditions10/19/2005 5:11:13 PM